Louisiana Cancer Facts & Figures, Kidney and Renal Pelvis Cancer, 2016

Size: px
Start display at page:

Download "Louisiana Cancer Facts & Figures, Kidney and Renal Pelvis Cancer, 2016"

Transcription

1 Louisiana Cancer Facts & Figures, Kidney and Renal Pelvis Cancer, 2016 Louisiana Tumor Registry December 5, 2016

2 Kidney and Renal Pelvis Cancer From 2009 to 2013, Louisiana had the highest incidence rate for kidney and renal pelvis cancer, and the 2 nd highest mortality rate of any state in the nation (all races and sexes combined). 1 About 1,140 new kidney and renal pelvis cancers are expected to be diagnosed and about 260 people are expected to die of kidney and renal pelvis cancers in Louisiana in ,3 1 Data source: NCI state cancer profile. 2 Data source: American Cancer Society, Cancer Facts & Figures ICD-O-3/WHO 2008 code: C649, C659; excluding ICD-O-3 histology (type): , 9140,

3 Kidney and Renal Pelvis Cancer: Incidence Rates 1,2, %* %* 25 45%* Louisiana U.S. 20%* White Males Black Males White Females Black Females 1 Age-adjusted to the 2000 U.S. standard population. 2 U.S. Incidence data source:18 SEER registries. * Incidence rate of Louisiana is significantly different from that of the U.S.

4 Incidence Rates of Kidney and Renal Pelvis Cancer in the U.S., All Races, Both Sexes, Louisiana: Rate: 21.2 per 100,000 Rank: 1st

5 160 Kidney and Renal Pelvis Cancer: Age-Specific Incidence Rates in Louisiana by Race and Gender, White Male Rate Per 100, Black Male White Female Black Female Age at Diagnosis U.S. data source:18 SEER registries.

6 Kidney and Renal Pelvis Cancer: Age-Specific Incidence Rates by Gender, Rate Per 100, LA Male U.S. Male LA Female U.S. female Age at Diagnosis U.S. data source:18 SEER registries.

7 Kidney and Renal Pelvis Cancer: Age-Specific Incidence Rates by Race, Rate Per 100, LA White U.S. White LA Black U.S. Black Age at Diagnosis U.S. data source:18 SEER registries.

8 Incidence Rates of Kidney and Renal Pelvis Cancer in the Louisiana, All Races, Both Sexes,

9 Kidney and Renal Pelvis Cancer Incidence 1,2 by Region: Louisiana, Whites, Rate Per 100, * 20.9* 23.9* 23.8* 22.2* 22* 20.3* 20.6* 21.8* 16.1* 1 Age-adjusted to the 2000 U.S. standard population. 2 Data source for U.S. was the 18 SEER registries. * Incidence rate of regions/louisiana is significantly different from that of the U.S.

10 Kidney and Renal Pelvis Cancer Incidence 1,2 by Region: Louisiana, Blacks, Rate Per 100, * 22.8* 24* * Age-adjusted to the 2000 U.S. standard population. 2 Data source for U.S. was the 18 SEER registries. * Incidence rate of regions/louisiana is significantly different from that of U.S.

11 Kidney and Renal Pelvis Cancer: Trends of Incidence Rates 1,2, Whites, LA Male LA Female U.S.Male U.S.Female Rate Per 100, Year of Diagnosis 1 Age-adjusted to the 2000 U.S. standard population. 2 US data source: 18 SEER registries.

12 Kidney and Renal Pelvis Cancer: Trends of Incidence Rates 1,2, Blacks, Rate Per 100, LA Male LA Female U.S. Male U.S Female Year of diagnosis 1 Age-adjusted to the 2000 U.S. standard population. 2 U.S. data source: 18 SEER registries.

13 Kidney and Renal Pelvis Cancer Mortality Rates 1 Louisiana vs. US 2, Louisiana U.S White Male Black Male While Female Black Female 1 Age-adjusted to the 2000 U.S. standard population. 2 Data source: National Center of Health Statistics (NCHS).

14 Mortality Rates of Kidney and Renal Pelvis Cancer in the U.S., All Races, Both Sexes, Louisiana: Rate: 5.0 per 100,000 Rank: 2nd

15 Mortality Rates of Kidney and Renal Pelvis Cancer in the Louisiana, All Races, Both Sexes, * Suppressed due to fewer than 16 cases.

16 Kidney and Renal Pelvis Cancer: Trends of Mortality Rates 1,2, Whites, Rate Per 100, LA Male U.S. Male LA Female U.S. Female Year of Death 1 Age-adjusted to the 2000 U.S. standard population. 2 Data source: National Center of Health Statistics (NCHS).

17 Kidney and Renal Pelvis Cancer: Trends of Mortality Rates 1,2, Blacks, Rate Per 100, LA Male LA Female U.S. Male U.S. Female Year of Death 1 Age-adjusted to the 2000 U.S. standard population. 2 Data source: National Center of Health Statistics (NCHS).

18 Kidney and Renal Pelvis Cancer: Trends of Incidence and Mortality Rates, by Race, Louisiana, Rate Per 100, Black Incidence (APC:3.2*) White Incidence (APC:3.0*) Black Mortality (APC:1.0*) White Mortality (APC:0) Year of Diagnosis/Death *APCs were calculated using weighted least squares method

19 Kidney and Renal Pelvis Cancer: Trends of Incidence and Mortality Rates, by Gender, Louisiana, Rate Per 100, Male Incidence (APC:2.7*) Female Incidence (APC:3.0*) Male Mortality (APC:0.2) Female Mortality (APC:-0.1) Year of Diagnosis/Death *APCs were calculated using weighted least squares method

20 Kidney and Renal Pelvis Cancer: Louisiana 5-Year Relative Survival by Stage 1, Both Sexes, All Races, Year Relative survival rate(%) 100% % 80% 70% % 50% 40% % 20% % 0% Localized Regional Distant Unstaged Regional 16% Percent of Cases by Stage Distant 16% Unstaged 2% Localized 66% 1 The stage distribution is based on Summary Stage 2000.

21 Kidney and Renal Pelvis Cancer: Louisiana 5-Year Relative Survival by Stage 1, White Males, Year Relative survival rate(%) 100% 80% 60% 40% 20% Regional 18% Percent of Cases by Stage Distant 17% Unstaged 1% Localized 64% 0% Localized Regional Distant Unstaged 1 The stage distribution is based on Summary Stage 2000.

22 5-Year Relative survival rate(%) Kidney and Renal Pelvis Cancer: Louisiana 5-Year Relative Survival by Stage 1, White Females, % 80% 60% 40% 20% 0% Localized Regional Distant Unstaged Percent of Cases by Stage Regional 15% Distant 15% Unstaged 2% Localized 68% 1 The stage distribution is based on Summary Stage 2000.

23 5-Year Relative survival rate(%) Kidney and Renal Pelvis Cancer: Louisiana 5-Year Relative Survival by Stage 1, Black Males, % 80% 60% 40% 20% 0% Localized Regional Distant Unstaged Regional 15% Percent of Cases by Stage Distant 18% Unstaged 2% localized 65% 1 The stage distribution is based on Summary Stage 2000.

24 5-Year Relative survival rate(%) Kidney and Renal Pelvis Cancer: Louisiana 5-Year Relative Survival by Stage 1, Black Females, Louisiana, % 80% 60% 40% 20% % Localized Regional Distant Regional 13% Percent of Cases by Stage Distant 14% Localized 73% 1 The stage distribution is based on Derived Summary Stage * The Unstaged 5-year relative survival could not be calculated due to lack of cases.

25 Data Sources Surveillance, Epidemiology, and End Results (SEER) Program ( SEER*Stat Databases, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2016, based on the November 2015 submission. For Incidence: Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2015 Sub ( ) <Katrina/Rita Population Adjustment> SEER*DMS - LTR , June 7, 2016 For Mortality: mortality all COD, aggregated with States, Total U.S. ( ) <Katrina/Rita Population Adjustment> For Survival: Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2015 Sub ( varying) Louisiana Tumor Registry

26 Acknowledgements Hospital cancer registries ( Louisiana Cancer Registrars Association ( Physicians and staff members in: Medical records offices Pathology laboratories Physician offices and clinics Hospice programs and nursing homes Regional and central offices of the Louisiana Tumor Registry ( School of Public Health, LSU Health Sciences Center New Orleans Louisiana Cancer and Lung Trust Fund Board Coroners offices

27 Sources of LTR Funding National Cancer Institute, SEER Program National Program of Cancer Registries, CDC Louisiana Health Care Services Division

28 Editors Shuang Yang, MPH Meichin Hsieh, PhD, MSPH, CTR Lauren Maniscalco, MPH Xiaocheng Wu, MD, MPH, CTR Contributors Xiangrong Li, MD, MSPH Brent Mumphrey, BS Tina Lefante, MPH Lisa Pareti, BS, RHIT, CTR Yong Yi, PhD, MS

29 Questions? Contact: or 504/

Louisiana Cancer Facts & Figures, Urinary Bladder Cancer, 2016

Louisiana Cancer Facts & Figures, Urinary Bladder Cancer, 2016 Louisiana Cancer Facts & Figures, Urinary Bladder Cancer, 2016 Louisiana Tumor Registry September, 2016 Urinary Bladder Cancer* From 2009 to 2013, urinary bladder cancer was the 7 th most common cancer

More information

Louisiana Cancer Facts & Figures, Pancreatic Cancer, 2016

Louisiana Cancer Facts & Figures, Pancreatic Cancer, 2016 Louisiana Cancer Facts & Figures, Pancreatic Cancer, 2016 Louisiana Tumor Registry September, 2016 Pancreatic Cancer * Pancreatic cancer was the 10 th most commonly diagnosed cancer in Louisiana, and 12

More information

Louisiana Cancer Facts & Figures, Oral Cavity and Pharynx Cancer, 2016

Louisiana Cancer Facts & Figures, Oral Cavity and Pharynx Cancer, 2016 Louisiana Cancer Facts & Figures, Oral Cavity and Pharynx Cancer, 2016 Louisiana Tumor Registry September, 2016 Oral Cavity and Pharynx Cancer* Oral cavity and pharynx cancer was the 12 th most commonly

More information

Louisiana Cancer Facts & Figures, Stomach Cancer

Louisiana Cancer Facts & Figures, Stomach Cancer Louisiana Cancer Facts & Figures, Stomach Cancer Louisiana Tumor Registry January 5, 2016 Stomach Cancer* Stomach cancer was the 17 th most commonly diagnosed cancer in both the U.S. and in Louisiana.

More information

Louisiana Cancer Facts & Figures, Liver and Intrahepatic Bile Duct Cancer, 2016

Louisiana Cancer Facts & Figures, Liver and Intrahepatic Bile Duct Cancer, 2016 Louisiana Cancer Facts & Figures, Liver and Intrahepatic Bile Duct Cancer, 16 Louisiana Tumor Registry March, 17 Liver and Intrahepatic Bile Duct Cancer Liver and intrahepatic bile duct cancer was the

More information

Louisiana Cancer Facts & Figures, Cervical Cancer, 2016

Louisiana Cancer Facts & Figures, Cervical Cancer, 2016 Louisiana Cancer Facts & Figures, Cervical Cancer, 06 Louisiana Tumor Registry September, 06 Cervical Cancer * Cervical cancer was the 5 th most commonly diagnosed cancer in Louisiana, and 6 th in the

More information

Louisiana Cancer Facts & Figures, Non-Hodgkin Lymphoma, 2016

Louisiana Cancer Facts & Figures, Non-Hodgkin Lymphoma, 2016 Louisiana Cancer Facts & Figures, Non-Hodgkin Lymphoma, 2016 Louisiana Tumor Registry September, 2016 Non-Hodgkin Lymphoma Non-Hodgkin lymphoma was the 6th most common cancer in Louisiana, and the 8th

More information

Louisiana Cancer Facts & Figures, Lung & Bronchus Cancer, 2016

Louisiana Cancer Facts & Figures, Lung & Bronchus Cancer, 2016 Louisiana Cancer Facts & Figures, Lung & Bronchus Cancer, 2016 Louisiana Tumor Registry February, 2017 Lung & Bronchus Cancer Lung cancer was the 2nd most common cancer and the leading cause of cancer

More information

Louisiana Cancer Facts & Figures, Prostate Cancer, 2016

Louisiana Cancer Facts & Figures, Prostate Cancer, 2016 Louisiana Cancer Facts & Figures, Prostate Cancer, 2016 Louisiana Tumor Registry February, 2017 Prostate Cancer Prostate cancer was the most common cancer and the 2nd leading cause of cancer deaths in

More information

Louisiana Cancer Facts & Figures, Myeloma

Louisiana Cancer Facts & Figures, Myeloma Louisiana Cancer Facts & Figures, Myeloma Louisiana Tumor Registry January 5, 6 Myeloma* Myeloma was the 8 th most commonly diagnosed cancer in Louisiana and the 9 th in the U.S. It was the 6 th leading

More information

Louisiana Cancer Facts & Figures, Kidney and Renal Pelvis Cancer

Louisiana Cancer Facts & Figures, Kidney and Renal Pelvis Cancer Louisiana Cancer Facts & Figures, Kidney and Renal Pelvis Cancer Louisiana Tumor Registry December 5, 2016 Kidney and Renal Pelvis Cancer From 2010 to 2014, Louisiana had the highest incidence rate for

More information

Louisiana Cancer Facts & Figures, Melanoma of the Skin

Louisiana Cancer Facts & Figures, Melanoma of the Skin Louisiana Cancer Facts & Figures, Melanoma of the Skin Louisiana Tumor Registry September, 2017 Melanoma of the Skin* Melanoma of the skin was the 6 th most commonly diagnosed cancer in U.S. and the 9

More information

Louisiana Cancer Facts & Figures, Ovarian Cancer, 2016

Louisiana Cancer Facts & Figures, Ovarian Cancer, 2016 Louisiana Cancer Facts & Figures, Ovarian Cancer, 2016 Louisiana Tumor Registry September, 2016 Ovarian Cancer Ovarian cancer was the 18th most common cancer in Louisiana and the 13 th most common cancer

More information

Louisiana Cancer Facts & Figures, Oral Cavity and Pharynx Cancer

Louisiana Cancer Facts & Figures, Oral Cavity and Pharynx Cancer Louisiana Cancer Facts & Figures, Oral Cavity and Pharynx Cancer Louisiana Tumor Registry September, 2017 Oral Cavity and Pharynx Cancer* From 2010 to 2014, Louisiana had the 3 rd highest incidence rate

More information

Louisiana Cancer Facts & Figures, Thyroid Cancer

Louisiana Cancer Facts & Figures, Thyroid Cancer Louisiana Cancer Facts & Figures, Thyroid Cancer Louisiana Tumor Registry September, 207 Thyroid Cancer* From 200 to 204, Louisiana had the 32 nd highest incidence rate and 44 th highest death rate of

More information

Louisiana Cancer Facts & Figures, Lung and Bronchus Cancer

Louisiana Cancer Facts & Figures, Lung and Bronchus Cancer Louisiana Cancer Facts & Figures, Lung and Bronchus Cancer Louisiana Tumor Registry July, 2017 Lung and Bronchus Cancer Lung cancer was the 1st most common cancer and the leading cause of cancer deaths

More information

Louisiana Cancer Facts & Figures, Non-Hodgkin Lymphoma

Louisiana Cancer Facts & Figures, Non-Hodgkin Lymphoma Louisiana Cancer Facts & Figures, Non-Hodgkin Lymphoma Louisiana Tumor Registry July, 2017 Non-Hodgkin Lymphoma Non-Hodgkin lymphoma was the 6th most common cancer and the 8 th leading cause of cancer

More information

Louisiana Cancer Facts & Figures, Ovarian Cancer

Louisiana Cancer Facts & Figures, Ovarian Cancer Louisiana Cancer Facts & Figures, Ovarian Cancer Louisiana Tumor Registry July, 2017 Ovarian Cancer Ovarian cancer was the 14th most common cancer and the 8 th leading cause of cancer death in Louisiana

More information

Louisiana Cancer Facts & Figures, Liver and Intrahepatic Bile Duct Cancer

Louisiana Cancer Facts & Figures, Liver and Intrahepatic Bile Duct Cancer Louisiana Cancer Facts & Figures, Liver and Intrahepatic Bile Duct Cancer Louisiana Tumor Registry September, 2017 Liver and Intrahepatic Bile Duct Cancer From 2010 to 2014, Louisiana had the 7th highest

More information

Louisiana Cancer Facts & Figures, Myeloma

Louisiana Cancer Facts & Figures, Myeloma Louisiana Cancer Facts & Figures, Myeloma Louisiana Tumor Registry September, 07 Myeloma* From 00 to 04, Louisiana had the 7 th highest incidence rate and the 5 th highest death rate of myeloma of any

More information

Louisiana Cancer Facts & Figures, Colon and Rectum Cancer, 2013

Louisiana Cancer Facts & Figures, Colon and Rectum Cancer, 2013 Louisiana Cancer Facts & Figures, Colon and Rectum Cancer, 23 Louisiana Tumor Registry Xiang-Rong Li, MD, MSPH October, 23 Colon and Rectum Cancer Colon and rectum cancer was the fourth most common cancer

More information

Louisiana Cancer Facts & Figures, Lung & Bronchus Cancer, 2013

Louisiana Cancer Facts & Figures, Lung & Bronchus Cancer, 2013 Louisiana Cancer Facts & Figures, Lung & Bronchus Cancer, 23 Louisiana Tumor Registry Xiang-Rong Li, MD, MSPH October, 23 Lung and Bronchus Cancer Lung Cancer was the second most common cancer and the

More information

Risk Factors in African-American Women. Michele L. Cote, PhD Associate Professor Wayne State t University

Risk Factors in African-American Women. Michele L. Cote, PhD Associate Professor Wayne State t University Risk Factors in African-American Women Michele L. Cote, PhD Associate Professor Wayne State t University it Age Adjusted Incidence and Mortality Rates for all Endometrial Cancers 2000-2010 by Race/Ethnicity

More information

Current HPV-Related Cancer Rates New Jersey State Cancer Registry

Current HPV-Related Cancer Rates New Jersey State Cancer Registry Current HPV-Related Cancer Rates New Jersey State Cancer Registry Antoinette M. Stroup, PhD, Director HPV NJ Roundtable October 11, 2017 American Cancer Society South Brunswick, NJ Rutgers, The State University

More information

Errata Corrected 17 January, 2017

Errata Corrected 17 January, 2017 Errata Corrected 17 January, 2017 Previously, colorectal cancer was erroneously omitted as the second leading cancer, by frequency, among Alaska Native Women in the Interior Tribal Health Region from 1984

More information

BREAST CANCER IN TARRANT COUNTY: Screening, Incidence, Mortality, and Stage at Diagnosis

BREAST CANCER IN TARRANT COUNTY: Screening, Incidence, Mortality, and Stage at Diagnosis NIMHD* CENTER OF EXCELLENCE: COMMUNITY OUTREACH CORE* BREAST CANCER IN TARRANT COUNTY: Screening, Incidence, Mortality, and Stage at Diagnosis Updated January 2014 *Supported by the National Institute

More information

Louisiana Cancer Facts & Figures Lung Cancer 2016

Louisiana Cancer Facts & Figures Lung Cancer 2016 Louisiana Cancer Facts & Figures Lung Cancer 2016 Louisiana Tumor Registry June 2016 1 Louisiana Tumor Registry Cancer Facts & Figures, Lung Cancer 2016 Contents Contents: Contents... 2 Introduction to

More information

Building Bridges. Hospital Registries: Louisiana Experience. with. Vivien W. Chen, PhD Louisiana Tumor Registry NAACCR Conference, June 5-7, 2012

Building Bridges. Hospital Registries: Louisiana Experience. with. Vivien W. Chen, PhD Louisiana Tumor Registry NAACCR Conference, June 5-7, 2012 Building Bridges with Hospital Registries: Louisiana Experience Vivien W. Chen, PhD Louisiana Tumor Registry NAACCR Conference, June 5-7, 2012 Background Purpose Methods Results Implications/Next steps

More information

Pediatric Cancer in Idaho,

Pediatric Cancer in Idaho, Pediatric Cancer in Idaho, 1996-2006 Although relatively rare in comparison with cancer in older adults, cancer is the second leading cause of death in persons aged 1-14 years. The epidemiology of cancer

More information

Case Investigation of Cervical Cancer (CICC) Study in 3 US Cancer Registries Vicki Benard Cancer Surveillance Branch

Case Investigation of Cervical Cancer (CICC) Study in 3 US Cancer Registries Vicki Benard Cancer Surveillance Branch Case Investigation of Cervical Cancer (CICC) Study in 3 US Cancer Registries Vicki Benard Cancer Surveillance Branch NAACCR June 22, 2017 Cervical Cancer Natural History Most HPV infections clear spontaneously

More information

A post-psa Update on Trends in Prostate Cancer Incidence. Ann Hamilton and Myles Cockburn Keck School of Medicine, USC, Los Angeles

A post-psa Update on Trends in Prostate Cancer Incidence. Ann Hamilton and Myles Cockburn Keck School of Medicine, USC, Los Angeles A post-psa Update on Trends in Prostate Cancer Incidence Ann Hamilton and Myles Cockburn Keck School of Medicine, USC, Los Angeles Background 1986: FDA approved PSA test to monitor disease status in prostate

More information

PEDIATRIC CANCER IN IDAHO

PEDIATRIC CANCER IN IDAHO PEDIATRIC CANCER IN IDAHO 2001-2010 May 2013 A Publication of the ACKNOWLEDGMENTS The Idaho Hospital Association (IHA) contracts with, and receives funding from, the Idaho Department of Health and Welfare,

More information

PEDIATRIC CANCER IN IDAHO

PEDIATRIC CANCER IN IDAHO PEDIATRIC CANCER IN IDAHO 1999-2008 May 2011 A Publication of the ACKNOWLEDGMENTS The Idaho Hospital Association (IHA) contracts with, and receives funding from, the Idaho Department of Health and Welfare,

More information

Centers for Disease Control and Prevention (CDC)

Centers for Disease Control and Prevention (CDC) American Cancer Society Ahmedin Jemal, DVM, PhD; Helmneh M. Sineshaw, MD, MPH Centers for Disease Control and Prevention (CDC) Manxia Wu, MD, MPH Florida Cancer Data System Brad Alan Wohler-Torres, MSc

More information

Comparative Analysis of Stage and Other Prognostic Factors Among Urethral, Ureteral, and Renal Pelvis Malignant Tumors

Comparative Analysis of Stage and Other Prognostic Factors Among Urethral, Ureteral, and Renal Pelvis Malignant Tumors Comparative Analysis of Stage and Other Prognostic Factors Among Urethral, Ureteral, and Renal Pelvis Malignant Tumors Presented to NAACCR Annual Conference 2012 Serban Negoita, MD, DrPH; Marsha Dunn,

More information

Construction of a North American Cancer Survival Index to Measure Progress of Cancer Control Efforts

Construction of a North American Cancer Survival Index to Measure Progress of Cancer Control Efforts Construction of a North American Cancer Survival Index to Measure Progress of Cancer Control Efforts Chris Johnson, Cancer Data Registry of Idaho NAACCR 2016 Annual Conference June 14, 2016 Concurrent

More information

Benign/Borderline Brain and ONS Tumors in the NAACCR Data

Benign/Borderline Brain and ONS Tumors in the NAACCR Data Benign/Borderline Brain and ONS Tumors in the NAACCR Data DURC Data Assessment Work Group Bin Huang 2011 NAACCR Conference 6/23/2011 Authors Louisiana Tumor Registry Patricia Andrews, MPH Meichin Hsieh,

More information

Vivien W. Chen, PhD Mei-Chin Hsieh, MSPH, CTR Lisa A. Pareti, BS, CTR Xiao-Cheng Wu, MD, MPH, CTR. NAACCR Conference Portland, Oregon, June 5-7, 2012

Vivien W. Chen, PhD Mei-Chin Hsieh, MSPH, CTR Lisa A. Pareti, BS, CTR Xiao-Cheng Wu, MD, MPH, CTR. NAACCR Conference Portland, Oregon, June 5-7, 2012 Vivien W. Chen, PhD Mei-Chin Hsieh, MSPH, CTR Lisa A. Pareti, BS, CTR Xiao-Cheng Wu, MD, MPH, CTR NAACCR Conference Portland, Oregon, June 5-7, 2012 Background Purpose/Objective Methods Results Implications/Next

More information

Annual Report to the Nation on the Status of Cancer, , with a Special Feature Regarding Survival

Annual Report to the Nation on the Status of Cancer, , with a Special Feature Regarding Survival University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Public Health Resources Public Health Resources 7-1-2004 Annual Report to the Nation on the Status of Cancer, 1975 2001,

More information

Incidence of HPV-Associated Head and Neck Cancers by Sub-site Among Diverse Racial/Ethnic Populations in the United States

Incidence of HPV-Associated Head and Neck Cancers by Sub-site Among Diverse Racial/Ethnic Populations in the United States Incidence of HPV-Associated Head and Neck Cancers by Sub-site Among Diverse Racial/Ethnic Populations in the United States Louisiana Tumor Registry LSUHSC School of Public Health Lauren Cole, MPH Linda

More information

Ethnic Disparities in the Treatment of Stage I Non-small Cell Lung Cancer. Juan P. Wisnivesky, MD, MPH, Thomas McGinn, MD, MPH, Claudia Henschke, PhD,

Ethnic Disparities in the Treatment of Stage I Non-small Cell Lung Cancer. Juan P. Wisnivesky, MD, MPH, Thomas McGinn, MD, MPH, Claudia Henschke, PhD, Ethnic Disparities in the Treatment of Stage I Non-small Cell Lung Cancer Juan P. Wisnivesky, MD, MPH, Thomas McGinn, MD, MPH, Claudia Henschke, PhD, MD, Paul Hebert, PhD, Michael C. Iannuzzi, MD, and

More information

CANCER IN IDAHO 2016 Preliminary

CANCER IN IDAHO 2016 Preliminary CANCER IN IDAHO 2016 Preliminary November 2017 A Publication of the Cancer Data Registry of Idaho Editors: Christopher J. Johnson, MPH, Epidemiologist Stacey L. Carson, RHIT, Vice President Operations

More information

Incidence of Primary Liver Cancer in American Indians and Alaska Natives

Incidence of Primary Liver Cancer in American Indians and Alaska Natives Incidence of Primary Liver Cancer in American Indians and Alaska Natives Stephanie C. Melkonian, PhD Epidemiologist Epidemiology and Applied Research Branch NAACCR Annual Conference June 21, 2017 Overview

More information

IASLC 2011/WHO 2015 CLASSIFICATION OF LUNG ADENOCARCINOMAS

IASLC 2011/WHO 2015 CLASSIFICATION OF LUNG ADENOCARCINOMAS Serban Negoita Dylan Holt Marsha Dunn IASLC 2011/WHO 2015 CLASSIFICATION OF LUNG ADENOCARCINOMAS DEMOGRAPHIC PATTERNS, TRENDS, AND IMPLICATIONS FOR CANCER SURVEILLANCE Outline Relevance of lung adenocarcinoma

More information

Cancer Statistics, 2008

Cancer Statistics, 2008 CA Cancer J Clin 8;58:71 96 Cancer Statistics, 8 Ahmedin Jemal, DVM, PhD; Rebecca Siegel, MPH; Elizabeth Ward, PhD; Yongping Hao, PhD; Jiaquan Xu*, MD; Taylor Murray; Michael J. Thun, MD, MS ABSTRACT Each

More information

Annual Report to the Nation on the Status of Cancer, , Featuring the Increasing Incidence of Liver Cancer

Annual Report to the Nation on the Status of Cancer, , Featuring the Increasing Incidence of Liver Cancer Annual Report to the Nation on the Status of Cancer, 1975-, Featuring the Increasing Incidence of Liver Cancer A. Blythe Ryerson, PhD, MPH 1 ; Christie R. Eheman, PhD, MSHP 1 ; Sean F. Altekruse, DVM,

More information

The Cancer Burden in California. Janet Bates MD MPH California Cancer Registry California Department of Public Health April 25, 2012

The Cancer Burden in California. Janet Bates MD MPH California Cancer Registry California Department of Public Health April 25, 2012 The Cancer Burden in California Janet Bates MD MPH California Cancer Registry California Department of Public Health April 25, 2012 Goals Introduce you to the California Cancer Registry (CCR) Provide an

More information

Chester Schmaltz, PhD Dept. of Health Management & Informatics, School of Medicine Missouri Cancer Registry and Research Center (MCR-ARC) University

Chester Schmaltz, PhD Dept. of Health Management & Informatics, School of Medicine Missouri Cancer Registry and Research Center (MCR-ARC) University Chester Schmaltz, PhD Dept. of Health Management & Informatics, School of Medicine Missouri Cancer Registry and Research Center (MCR-ARC) University of Missouri Columbia Chester Schmaltz, PhD The following

More information

Cancer Statistics, 2010 Ahmedin Jemal, Rebecca Siegel, Jiaquan Xu and Elizabeth Ward. DOI: /caac.20073

Cancer Statistics, 2010 Ahmedin Jemal, Rebecca Siegel, Jiaquan Xu and Elizabeth Ward. DOI: /caac.20073 Statistics, 21 Ahmedin Jemal, Rebecca Siegel, Jiaquan Xu and Elizabeth Ward CA J Clin 21;6;277-3; originally published online Jul 7, 21; DOI: 1.3322/caac.273 This information is current as of February

More information

Incidence-based Mortality Method to Partition Tumor-Specific Mortality Trends: Application to Non-Hodgkin Lymphoma Cancer

Incidence-based Mortality Method to Partition Tumor-Specific Mortality Trends: Application to Non-Hodgkin Lymphoma Cancer Incidence-based Mortality Method to Partition Tumor-Specific Mortality Trends: Application to Non-Hodgkin Lymphoma Cancer Nadia Howlader, Lindsay M Morton, Eric J Feuer, Caroline Besson, Eric A Engels

More information

Melanoma Surveillance in the United States: Overview of Methods

Melanoma Surveillance in the United States: Overview of Methods Melanoma Surveillance in the United States: Overview of Methods Meg Watson, MPH Epidemiologist Epidemiology and Applied Research Branch Division of Cancer Prevention and Control Centers for Disease Control

More information

Characteristics, treatment patterns, and survival outcomes of primary GI melanoma cases compared to cutaneous melanoma, SEER:

Characteristics, treatment patterns, and survival outcomes of primary GI melanoma cases compared to cutaneous melanoma, SEER: Characteristics, treatment patterns, and survival outcomes of primary GI melanoma cases compared to cutaneous melanoma, SEER:1973-2015 Amanda Kahl, MPH Mary E. Charlton, PhD, Imran Hassan, MD, Paolo Goffredo,

More information

of Nebraska - Lincoln

of Nebraska - Lincoln University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Public Health Resources Public Health Resources 2012 Annual Report to the Nation on the Status of Cancer, 1975-, Featuring

More information

Cancer Statistics, 2011

Cancer Statistics, 2011 Cancer Statistics, 2011 Cancer Statistics, 2011 The Impact of Eliminating Socioeconomic and Racial Disparities on Premature Cancer Deaths Rebecca Siegel, MPH 1 ; Elizabeth Ward, PhD 2 ; Otis Brawley, MD

More information

Annual Report to the Nation on the Status of Cancer, , Featuring Survival Questions and Answers

Annual Report to the Nation on the Status of Cancer, , Featuring Survival Questions and Answers EMBARGOED FOR RELEASE CONTACT: Friday, March 31, 2017 NCI Media Relations Branch: (301) 496-6641 or 10:00 am EDT ncipressofficers@mail.nih.gov NAACCR: (217) 698-0800 or bkohler@naaccr.org ACS Press Office:

More information

CDC HPV Typing of Cancers Study: Evaluating Representativeness

CDC HPV Typing of Cancers Study: Evaluating Representativeness CDC HPV Typing of Cancers Study: Evaluating Representativeness NAACCR Annual Conference June 22, 2011 Meg Watson, MPH National Center for Chronic Disease Prevention and Health Promotion Division of Cancer

More information

PEDIATRIC CANCER IN IDAHO

PEDIATRIC CANCER IN IDAHO PEDIATRIC CANCER IN IDAHO 2006-2015 A Publication of the ACKNOWLEDGMENTS The Idaho Hospital Association (IHA) contracts with, and receives funding from, the Idaho Department of Health and Welfare, Division

More information

Cancer Statistics, 2009 Ahmedin Jemal, Rebecca Siegel, Elizabeth Ward, Yongping Hao, Jiaquan Xu and Michael J. Thun. DOI: /caac.

Cancer Statistics, 2009 Ahmedin Jemal, Rebecca Siegel, Elizabeth Ward, Yongping Hao, Jiaquan Xu and Michael J. Thun. DOI: /caac. Cancer Statistics, 2009 Ahmedin Jemal, Rebecca Siegel, Elizabeth Ward, Yongping Hao, Jiaquan Xu and Michael J. Thun CA Cancer J Clin 2009;59;225-249; originally published online May 27, 2009; DOI: 10.3322/caac.20006

More information

Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score

Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score Cancer Medicine ORIGINAL RESEARCH Open Access Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score Kimberly A. Herget 1, Darshan P. Patel 2,3, Heidi A. Hanson

More information

NAACCR WEBINAR: ABSTRACTING THYROID/LARYNX CANCER INCIDENCE FLORIDA: PEDIATRIC CANCER ADMISSIONS (TOTAL), ANALYTIC CASES ONLY FCDS REGISTER VOL.

NAACCR WEBINAR: ABSTRACTING THYROID/LARYNX CANCER INCIDENCE FLORIDA: PEDIATRIC CANCER ADMISSIONS (TOTAL), ANALYTIC CASES ONLY FCDS REGISTER VOL. NAACCR WEBINAR: ABSTRACTING THYROID/LARYNX CANCER INCIDENCE AND TREATMENT DATA ON 3/6/2008. SESSION #5 OF 8 IS BEING HELD AT BOCA RATON COMMUNITY HOSPITAL, MOFFITT CANCER CENTER, AND SHANDS UNIVERSITY

More information

Opportunities for Cancer Control An overview of screen-detectable and tobacco-related cancer in New Mexico

Opportunities for Cancer Control An overview of screen-detectable and tobacco-related cancer in New Mexico Opportunities for Cancer Control An overview of screen-detectable and tobacco-related cancer in New Mexico Prepared by the New Mexico Tumor Registry for the New Mexico Department of Health February 1,

More information

2007 Multiple Primary and Histology Coding Rules

2007 Multiple Primary and Histology Coding Rules National Cancer Institute 2007 Multiple Primary and Histology Coding Rules NCI SEER for NAACCR 2006 Conference U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Regina, Saskatchewan June 15, 2006 National Institutes

More information

Cancer of the Breast (Female) - Cancer Stat Facts

Cancer of the Breast (Female) - Cancer Stat Facts Page 1 of 9 Home Statistical Summaries Cancer Stat Facts Cancer of the Breast (Female) Cancer Stat Facts: Female Breast Cancer Statistics at a Glance At a Glance Estimated New Cases in 2016 % of All New

More information

THE BURDEN OF CANCER IN NEBRASKA: RECENT INCIDENCE AND MORTALITY DATA

THE BURDEN OF CANCER IN NEBRASKA: RECENT INCIDENCE AND MORTALITY DATA THE BURDEN OF CANCER IN NEBRASKA: RECENT INCIDENCE AND MORTALITY DATA Presented by: Bryan Rettig, MS Nebraska Dept. of Health & Human Services Division of Public Health May 31, 2017 Nebraska Cancer Registry

More information

Cancer in Utah: An Overview of Cancer Incidence and Mortality from

Cancer in Utah: An Overview of Cancer Incidence and Mortality from Cancer in Utah: An Overview of Cancer Incidence and Mortality from 1973-2010 A publication of the Utah Cancer Registry January 2014 Prepared by: C. Janna Harrell, MS Senior Research Analyst Kimberly A.

More information

Weight-Related Cancers in Florida

Weight-Related Cancers in Florida Weight-Related Cancers in Florida 1992-2013 2018 Monique Hernandez, PhD David Lee, PhD Tara Hylton, MPH Steven Peace, BS, CTR Joseph Lowry, MPH Judy Bonner, RN, MS, CTR U N I V E R S I T Y OF M I A M I

More information

Rare Cancer Prevalence in the SEER Population: Hepatobiliary Cancers,

Rare Cancer Prevalence in the SEER Population: Hepatobiliary Cancers, Rare Cancer Prevalence in the SEER Population: Hepatobiliary Cancers, 1975-2015 NAACCR 2018 Annual Conference Andrea Ayers, MPH Outline 1. Rare cancer classification 2. Hepatobiliary cancers 3. Key analytic

More information

Trends in Testicular Germ Cell Tumors Among U.S. Military Servicemen,

Trends in Testicular Germ Cell Tumors Among U.S. Military Servicemen, MILITARY MEDICINE, 176, 10:1184, 2011 Trends in Testicular Germ Cell Tumors Among U.S. Military Servicemen, 1990-2003 Lindsey Enewold, PhD*; Jing Zhou, MS*; Susan S. Devesa, PhDf; L Ralph L Erickson, MC

More information

CDC & Florida DOH Attribution

CDC & Florida DOH Attribution SCCRA/GATRA Regional Conference North Charleston, SC 11/6/2018 Steven Peace, CTR 1 CDC & Florida DOH Attribution Funding for this conference was made possible (in part) by the Centers for Disease Control

More information

Presentation for DHSS 14 September Senior Statistician

Presentation for DHSS 14 September Senior Statistician Presentation for DHSS 14 September 2014 Jeannette Jackson-Thompson, MSPH, PhD Director Chester Schmaltz, PhD Senior Statistician Missouri Cancer Registry and Research Center (MCR-ARC) University of Missouri

More information

The Quality of Cancer Registry Data: Preliminary Results from CDC-NPCR s Patterns of Care Study

The Quality of Cancer Registry Data: Preliminary Results from CDC-NPCR s Patterns of Care Study The Quality of Cancer Registry Data: Preliminary Results from CDC-NPCR s Patterns of Care Study Robert R. German, DrPH, MPH; Tim Byers, MD, MPH; Holly Wolf, PhD, MSPH; Jen Wike, MBA, MPH; Linda Alley,

More information

CINA Deluxe Data Quality Profile

CINA Deluxe Data Quality Profile CINA Deluxe Data Quality Profile Date DQP produced: February 9, 2018 Variable examined: CS Site-Specific Factor 1 (SSF1): Estrogen Receptor (ER) (NAACCR Data Item #: 2880) CS Site-Specific Factor 2 (SSF2):

More information

Suggested Citation: Production and design by Magdalena Burgos.

Suggested Citation: Production and design by Magdalena Burgos. This report was prepared by the CalCARES Program, Institute for Population Health Improvement, UC Davis Health System, for the Chronic Disease Surveillance and Research Branch, California Department of

More information

2018 IMPLEMENTATION UPDATE: WHAT S NEW IN STAGING FOR 2018?

2018 IMPLEMENTATION UPDATE: WHAT S NEW IN STAGING FOR 2018? 2018 IMPLEMENTATION UPDATE: WHAT S NEW IN STAGING FOR 2018? SESSION 2 10/20/17 Q&A Please submit all questions concerning webinar content through the Q&A panel. A recording of today s session, the Q&A,

More information

Thyroid cancer in the United States: Recent increases

Thyroid cancer in the United States: Recent increases Thyroid cancer in the United States: Recent increases Meg Watson Epidemiology and Applied Research Branch Division of Cancer Prevention and Control CDC NAACCR Annual Conference June 22, 2011 National Center

More information

Examining Subsequent Occurrence and Outcomes of Estrogen-related Cancers (Breast and Thyroid) in Missouri Women

Examining Subsequent Occurrence and Outcomes of Estrogen-related Cancers (Breast and Thyroid) in Missouri Women Examining Subsequent Occurrence and Outcomes of Estrogen-related Cancers (Breast and Thyroid) in Missouri Women Iris Zachary, PhD, MSHI, CTR; Jeannette Jackson-Thompson, MSPH, PhD; Chester Schmaltz, PhD

More information

Thymic neoplasms are the most common tumors of

Thymic neoplasms are the most common tumors of Thymic Carcinoma: A Multivariate Analysis of Factors Predictive of Survival in 290 Patients Benny Weksler, MD, Rajeev Dhupar, MD, MBA, Vishal Parikh, BS, Katie S. Nason, MD, MPH, Arjun Pennathur, MD, and

More information

Cancer Statistics for African Americans

Cancer Statistics for African Americans Cancer Statistics for African Americans Cancer Statistics for African Americans Asma Ghafoor, MPH; Ahmedin Jemal, PhD, DVM;Vilma Cokkinides, PhD, MSPH; Cheryll Cardinez, MSPH;Taylor Murray; Alicia Samuels,

More information

Incidence of Cancers Associated with Modifiable Risk Factors and Late Stage Diagnoses for Cancers Amenable to Screening Idaho

Incidence of Cancers Associated with Modifiable Risk Factors and Late Stage Diagnoses for Cancers Amenable to Screening Idaho Incidence of Cancers Associated with Modifiable Risk Factors and Late Stage Diagnoses for Cancers Amenable to Screening Idaho 2008-2011 August 2013 A Publication of the Cancer Data Registry of Idaho PO

More information

Cancer Statistics, 2007 Ahmedin Jemal, Rebecca Siegel, Elizabeth Ward, Taylor Murray, Jiaquan Xu and Michael J. Thun

Cancer Statistics, 2007 Ahmedin Jemal, Rebecca Siegel, Elizabeth Ward, Taylor Murray, Jiaquan Xu and Michael J. Thun Ahmedin Jemal, Rebecca Siegel, Elizabeth Ward, Taylor Murray, Jiaquan Xu and Michael J. Thun CA Cancer J Clin 2007;57;43-66 This information is current as of August 3, 2007 The online version of this article,

More information

Translating Medical Claims into Meaningful Cancer Data JUDY BONNER, RN, MS, CTR FLORIDA CANCER DATA SYSTEM ANNUAL MEETING JULY 27, 2016

Translating Medical Claims into Meaningful Cancer Data JUDY BONNER, RN, MS, CTR FLORIDA CANCER DATA SYSTEM ANNUAL MEETING JULY 27, 2016 Translating Medical Claims into Meaningful Cancer Data JUDY BONNER, RN, MS, CTR FLORIDA CANCER DATA SYSTEM ANNUAL MEETING JULY 27, 2016 Claims Project Background How did this begin? CER Study 2011-2013

More information

Colorectal Cancer in Idaho November 2, 2006 Chris Johnson, CDRI

Colorectal Cancer in Idaho November 2, 2006 Chris Johnson, CDRI Colorectal Cancer in Idaho 2002-2004 November 2, 2006 Chris Johnson, CDRI cjohnson@teamiha.org Colorectal Cancer in Idaho, 2002-2004 Fast facts: Colorectal cancer is the second leading cause of cancer

More information

Trends in Colorectal Cancer Incidence Among Younger Adults- Disparities by Subsite, Age, Sex, Race, Ethnicity, and Stage

Trends in Colorectal Cancer Incidence Among Younger Adults- Disparities by Subsite, Age, Sex, Race, Ethnicity, and Stage Trends in Colorectal Cancer Incidence Among Younger Adults- Disparities by Subsite, Age, Sex, Race, Ethnicity, and Stage Amanda B. Crosbie 1, Lisa M. Roche 1, Linda Johnson, CTR, Karen S. Pawlish 1, Lisa

More information

Cancer in Rural Illinois, Incidence, Mortality, Staging, and Access to Care. April 2014

Cancer in Rural Illinois, Incidence, Mortality, Staging, and Access to Care. April 2014 Cancer in Rural Illinois, 1990-2010 Incidence, Mortality, Staging, and Access to Care April 2014 Prepared by Whitney E. Zahnd, MS Research Development Coordinator Center for Clinical Research Southern

More information

Incidence of Cancers Associated with Modifiable Risk Factors and Late Stage Diagnoses for Cancers Amenable to Screening Idaho

Incidence of Cancers Associated with Modifiable Risk Factors and Late Stage Diagnoses for Cancers Amenable to Screening Idaho Incidence of Cancers Associated with Modifiable Risk Factors and Late Stage Diagnoses for Cancers Amenable to Screening Idaho 2009-2012 June 2015 A Publication of the Cancer Data Registry of Idaho PO Box

More information

Utilization of OncoType DX Test for

Utilization of OncoType DX Test for Utilization of OncoType DX Test for Breast Cancer in the Community Setting XC Wu, XR Li, V Petkov, MC Hsieh, M Loch, PA Andrews, VW Chen 2016 NAACCR Annual Conference June 8, 2016 Background Chemotherapy

More information

Changing Incidence of Hodgkin Lymphoma Histologic Subtypes: Risk Factor Trends or Evolving Diagnostic Practice?

Changing Incidence of Hodgkin Lymphoma Histologic Subtypes: Risk Factor Trends or Evolving Diagnostic Practice? Changing Incidence of Hodgkin Lymphoma Histologic Subtypes: Risk Factor Trends or Evolving Diagnostic Practice? Greater Bay Area Cancer Registry Cancer Prevention Institute of California Stanford Cancer

More information

Suggested Citation: Copyright Information:

Suggested Citation: Copyright Information: This report was prepared by the CalCARES Program, Institute for Population Health Improvement, UC Davis Health System, for the Chronic Disease Surveillance and Research Branch, California Department of

More information

Cancer Registrars: Beyond the Abstract

Cancer Registrars: Beyond the Abstract Cancer Registrars: Beyond the Abstract Presented by Melissa Smith, RHIT, CTR Director of Client Services CHAMPS Oncology Objectives Identify what is a Certified Tumor Registrar (CTR) and how someone becomes

More information

Annual Report to the Nation on the Status of Cancer, , Featuring Survival

Annual Report to the Nation on the Status of Cancer, , Featuring Survival JNCI J Natl Cancer Inst (217) 19(9): djx3 doi: 1.193/jnci/djx3 First published online March 31, 217 Article Annual Report to the Nation on the Status of Cancer, 1975 214, Featuring Survival Ahmedin Jemal,

More information

Utility of an Early Case Capture Pediatric Cancer Registry

Utility of an Early Case Capture Pediatric Cancer Registry Utility of an Early Case Capture Pediatric Cancer Registry Mary Puckett, PhD Epidemic Intelligence Service Officer Comprehensive Cancer Control Branch National Center for Chronic Disease Prevention and

More information

SURVEILLANCE FOR BRCA AND LYNCH SYNDROME: Risk Criteria and Genetic Counseling and Testing Data for Cancer Cases

SURVEILLANCE FOR BRCA AND LYNCH SYNDROME: Risk Criteria and Genetic Counseling and Testing Data for Cancer Cases SURVEILLANCE FOR BRCA AND LYNCH SYNDROME: Risk Criteria and Genetic Counseling and Testing Data for Cancer Cases Carol Sweeney PhD Director, Utah Cancer Registry Supported by CDC UNIVERSITY OF UTAH HEALTH,

More information

PREVIEW OF REGISTRY-SPECIFIC AND AGGREGATED RELATIVE SURVIVAL ESTIMATES IN CANCER IN NORTH AMERICA

PREVIEW OF REGISTRY-SPECIFIC AND AGGREGATED RELATIVE SURVIVAL ESTIMATES IN CANCER IN NORTH AMERICA PREVIEW OF REGISTRY-SPECIFIC AND AGGREGATED RELATIVE SURVIVAL ESTIMATES IN CANCER IN NORTH AMERICA CINA SURVIVAL Authors: Chris Johnson, Deborah Hurley, Angela Mariotto, Reda Wilson, Donna Turner, Hannah

More information

NAACCR 2018 IMPLEMENTATION WEBINAR

NAACCR 2018 IMPLEMENTATION WEBINAR If you experience technical difficulties, Please call us at 217 698 0800 x 111 NAACCR 2018 IMPLEMENTATION WEBINAR NAACCR 2018 IMPLEMENTATION WG DECEMBER 18, 2017 HOUSEKEEPING We will address all questions

More information

CancerAmongAsiansandPacificIslanders

CancerAmongAsiansandPacificIslanders CancerAmongAsiansandPacificIslanders innewjersey 1990-2007 CancerEpidemiologyServices PublicHealthServicesBranch NewJerseyDepartmentofHealthandSeniorServices ChrisChristie,Governor Kim Guadagno,Lt.Governor

More information

Descriptive Epidemiology: U.S. Patterns

Descriptive Epidemiology: U.S. Patterns Descriptive Epidemiology: U.S. Patterns Linda Morris Brown, Gloria Gridley, and Susan S. Devesa Abbreviations US HN SEER HPV ICD-O-3 API AI/AN United States head and neck Surveillance, Epidemiology, and

More information

Quality Elm & Carlton Streets Buffalo, New York ASK-RPCI ( )

Quality Elm & Carlton Streets Buffalo, New York ASK-RPCI ( ) Elm & Carlton Streets Buffalo, New York 14263 www.roswellpark.org 1-877-ASK-RPCI (1-877-275-7724) A National Cancer Institute-designated Comprehensive Cancer Center A National Comprehensive Cancer Network

More information

Percent Surviving 5 Years 89.4%

Percent Surviving 5 Years 89.4% Page 1 of 8 Surveillance, Epidemiology, and End Results Program Turning Cancer Data Into Discovery Home Statistical Summaries Cancer Stat Fact Sheets Cancer of the Breast SEER Stat Fact Sheets: Breast

More information

North American Association of Central Cancer Registries. Standards for Cancer Registries Volume II. Data Standards and Data Dictionary

North American Association of Central Cancer Registries. Standards for Cancer Registries Volume II. Data Standards and Data Dictionary North American Association of Central Cancer Registries Standards for Cancer Registries Volume II Data Standards and Data Dictionary Seventh Edition Record Layout Version 10 Edited By Dianne Hultstrom

More information

Journal of Registry Management

Journal of Registry Management ISSN 1945-6123 Journal of Registry Management Winter 2011 Volume 38 Number 4 Published by the National Cancer Registrars Association Founded in 1975 as The Abstract United We Stand IN EDUCATION, ADVOCACY

More information